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Abstract
Background: Concerns have been expressed about risk of  exposure to exhaled aerosols to ICU personnel. 
AIM: To quantify amount of  aerosol collected at the exhaust outlet of  mechanical ventilators operated with 
and without filters in the expiratory limb. Methods: Two categories of  ventilators were tested: (1) Ventilators 
without Proprietary Filters: Servo-i (Maquet) and Galileo (Hamilton) and (2) Ventilator with proprietary filters: 
PB 840 (Covidien). Each ventilator was attached to a simple test lung and operated with VT 500 ml, RR 20 
bpm, PIF 50 L/min, PEEP 5 cmH2O. Four separate doses of  albuterol (2.5 mg/3mL) were administered via 
jet nebuliser (eValueMed, Tri-anim) placed at the “Y”. In Experiment A, a filter (Respirgard 303) was placed 
at the exhaust port. In Experiment B, two filters were attached to the ventilators without proprietary filters: 
(1) at the end of  expiratory limb and (2) at the exhaust outlet. Drug was eluted from filters and measured 
using spectrophotometry. Results: Drug deposited at the exhaust port without expiratory filtering was >160 
fold higher than with expiratory filtering. The collecting filter used in this study was less efficient than the 
proprietary filter designed for use with the ventilator. Regardless of  type of  filter used, placement of  filter in the 
expiratory limb reduced secondhand aerosol exposure significantly. Conclusion: Risk of  secondhand exposure 
to exhaled aerosol can account for >45% of  nominal dose as well as droplet nuclei produced by patients.  Using 
expiratory filters decreases risk of  exposure to aerosol released to the atmosphere during mechanical ventilation. 
Keywords: Aerosols, mechanical ventilation, secondhand aerosol exposure, and inhalation therapy.
Arzu Ari, PhD, RRT, PT, CPFT, FAARC
Associate Professor, Georgia State University, Division of 
Respiratory Therapy, Atlanta
James B Fink, PhD, RRT, FAARC, FCCP
Adjunct Professor, Georgia State University, Division of 
Respiratory Therapy, Atlanta 
Sue Pilbeam, MS, RRT, FAARC
Respiratory Therapist, Baptist Medical Center, Jacksonville, FL 
Respiratory Care Consultant, 9 Althea Street, Saint Augustine, FL 
32084
Secondhand aerosol exposure during mechanical 
ventilation with and without expiratory filters: An  
in-vitro study
Arzu Ari, James B Fink, Sue Pilbeam
Email: arzuari@hotmail.com
How to cite this article: Ari A, Fink JB, Pilbeam S. Secondhand aerosol exposure during mechanical ventilation with and 
without expiratory filters: An in-vitro study. Ind J Resp Care 2016; 5(1): 677-82.
Original article
Introduction
While many studies have quantified delivery of  
medical aerosols to the lungs of  mechanically 
ventilated patients, less is known about the fate of  
aerosols which are exhaled by the patient and those 
aerosols which bypass the patient completely.  Both 
types of  aerosol entering the ambient environment 
may result in ‘secondhand exposure’ and provide cause 
for concern.  Second hand exposure to medication 
intended for inhalation may have deleterious 
impact on care providers, visitors and other 
patients in the vicinity.   For example, secondhand 
exposure to inhaled bronchodilators by health care 
professionals has been associated with development 
of  occupational asthma.1-14  Respiratory therapists 
have an increased risk of  developing asthma after 
entering the profession.15,16  That may be explained 
in part by their work environment as they are 
responsible for patient care with inhaled medications, 
routine monitoring of  patients, equipment cleaning 
and maintenance that may cause exposure to a range 
of  aerosolised substances in the hospital setting. 
Some studies show that there is an economic impact 
of  respiratory-related work disability due to work 
loss and reported that better control of  workplace 
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exposure may reduce work disability caused by 
respiratory conditions.12,17-19
We know that patients while coughing, talking and 
even laughing can generate aerosols as droplet nuclei 
capable of  transmitting bacteria and viral vectors. 
Exhaled particles from intubated patients are likely to 
have mass median aerodynamic diameters (MMAD) 
of  less than 2 µm, as no particles of  a greater 
diameter than that have been observed exiting 
endotracheal tubes.  Particles in this range tend to 
not deposit via inertial impaction or sedimentation, 
and are capable of  remaining suspended in the air 
for extended periods of  time.  For infectious agents, 
where low concentration exposure is sufficient for 
transmission, exhaled patient generated aerosols 
may pose the most ominous risks. Exhaled particles 
from patients with pulmonary tuberculosis (TB) 
have been documented to infect other patients 
between wards and separate health care facilities.20,21  
Similarly, severe acute respiratory syndrome (SARS) 
and influenza A virus subtype H1N1 has been shown 
to be transmitted by droplet nuclei generated by 
patients.  Environmental exposure to antibacterial 
agents may also contribute to the development of  
resistant organisms and hence increase the risk 
of  airborne infection.22-25   Due to the proximity 
of  acutely ill patients within the hospital, it is 
reasonable to assume that pathogenic bacteria exist 
in higher concentrations in the hospital environment 
than in the home.   When aerosols containing 
antibiotics settle on surfaces in the patient room and 
vicinity, they may expose the ambient bacteria to 
concentrations that are well below the level required 
to kill the bacteria.  Low concentration exposure to 
antibiotics is associated with the development of  
species that are resistant to that antibiotic.26  
To the best of  our knowledge, none have described 
secondhand aerosol exposure during mechanical 
ventilation although aerosols are commonly 
administered to ventilator-dependent patients. 
Commercial mechanical ventilators vary in their 
approach to providing or recommending use of  
filters in the expiratory limb of  the ventilator 
circuit.  In many cases, such filters are required to 
reduce the volume of  drug depositing on sensors 
and/or valves distal to the exhalation limb of  the 
ventilator circuit.  Some ventilators are designed to 
require the use of  proprietary filters, while others 
do not, but recommend their use.
For this paper the term proprietary filter is defined 
as any filter required for use with a specific ventilator, 
which cannot be readily substituted with any other 
filter. They are typically larger, more complex high-
efficiency particulate air (HEPA) filters than other 
simpler, low volume expiratory filters that may be 
placed in the circuit. Despite its importance, there 
have been no studies showing the effect of  using 
expiratory or proprietary filters on ventilator–
dependent patients on secondhand aerosol exposure 
during mechanical ventilation. Therefore, the 
objective of  this study was to quantify the amount 
of  aerosol that exits from the ventilator exhaust 
port under a variety of  conditions ranging from no 
filter, to the use of  a filter placed in the circuit, to 
the more sophisticated proprietary filters integral to 
the ventilator.
Methods
Filtration and Ventilators: The types of  filtration 
that were tested with ventilators in this study were 
divided into two categories: 1) Ventilators without 
filters in the expiratory limb: The Servo-i (Maquet 
Inc, Wayne, NJ) and the Galileo (Hamilton Medical, 
Reno, NV), and (2) A ventilator with a proprietary 
filter in the expiratory limb: PB 840 (Covidien-
NellcorTM and Puritan BennettTM, Boulder, CO). 
Each ventilator was attached to a passive test lung 
and operated in volume control ventilation with 
adult parameters (VT 500 ml, RR 20 breaths/min, 
PIF 50 L/min, and PEEP 5 cmH2O).  
Experiments: As shown in Figure 1, in all 
experiments, a collecting filter was placed distal to the 
ventilator expiratory exhaust port.  In Experiment A, 
there was no filter at the end of  the expiratory limb 
with the aim of  determining secondhand aerosol 
exposure during mechanical ventilation without 
expiratory filtration.  In Experiment B, a filter 
(Respirgard II, Vital Signs, Englewood, Colorado) 
was placed in the expiratory limb proximal to the 
ventilator to determine the effect of  using a filter 
at the end of  the expiratory limb on secondhand 
aerosol exposure during mechanical ventilation. 
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Data collection:  For each experiment, albuterol 
(2.5 mg/3mL) was nebulised via a jet nebuliser 
(eValueMed, Tri-anim) placed in the inspiratory 
limb at the “Y” adaptor (n=3).  The nebuliser was 
operated continuously with 100% oxygen at 8 L/
min using a back pressure compensated flow meter 
(Timemeter, St. Louis, MO).  Nebulisation continued 
until 1 minute past initiation of  sputter.  Drug was 
eluted from the filters with 5 mL of   0.1 N HCl, with 
agitation for 1 minute.  Quantity of  eluted drug was 
determined by a UV spectrophotometer (Beckman 
Coulter) at 276 nm. 
Data analysis: The Statistical Package for Social 
Science version 18 (SPSS Inc, Chicago, IL) was 
used for the data analysis of  this study. Using 
descriptive statistics, secondhand aerosol exposure 
was expressed as a mean (± SD) percentage of  
the nominal dose placed in nebuliser.  Independent 
sample t-test and one way analysis of  variance 
(ANOVA) were conducted to compare the amount 
of  aerosol exiting from the exhaust port of  each 
ventilator. A p-value of  less than 0.05 was considered 
to be statistically significant.
Results
Table 1 shows the percent of  nominal dose (mean 
± standard deviation) delivered to the atmosphere 
through the ventilators with or without expiratory 
and proprietary filters.
Secondhand aerosol exposure without expiratory 
and proprietary filters:  The findings of  this study 
showed that drug deposited at the exhaust port of  
the ventilator without expiratory and proprietary 
filter ranged from 40% to 45% (Table 1).
The effect of  proprietary filters on secondhand 
aerosol exposure during mechanical ventilation: 
In Experiment A, comparisons of  drug deposited 
at the exhaust filter revealed significant differences 
between ventilators with and without proprietary 
filters (p=0.0001).  Drug deposited at the exhaust 
port with proprietary filters was 0.25% in PB 
840, which was 160 fold less than the ventilators 
without proprietary filters.  It was found that use 
of  proprietary filters with ventilators was the most 
efficient way of  preventing secondhand aerosol 
exposure.  
The effect of  expiratory filters on secondhand 
aerosol exposure during mechanical ventilation: 
After the placement of  expiratory filters on Servo-I 
and Hamilton Galileo in Experiment B, comparisons 
of  drug deposition at the exhaust and expiratory 
filters were repeated and a significant difference on 
Experiment A Experiment B
Figure 1: Illustrations of the experimental set-ups used in Experiment A and Experiment B
Table 1: Percent of nominal dose (mean ± standard deviation) delivered to the atmosphere through the ventilators with or without 
expiratory and proprietary filters.
Ventilators without Proprietary Filters
Ventilators with 
Proprietary Filters
Servo-i Hamilton Galileo PB 840
Experiment A Experiment B Experiment A Experiment B Experiment A
Exhaust Filter only Expiratory Filter Exhaust Filter Exhaust Filter only Expiratory Filter Exhaust Filter Exhaust Filter only
40.6 ± 0.21% 39.9 ± 10.4% 2.2 ± 1.2% 45.1 ± 5.1% 54.6 ± 5.3% 6.1 ± 0.7% 0.25 ± 0.1%
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the exhaust filter (p=0.007) was found, while there 
was no significant difference between drug deposited 
on the expiratory filters of  the Servo-i and the 
Hamilton Galileo (p=0.09).  As shown in Table 1, 
placement of  expiratory filters on the expiratory 
limb of  the ventilator circuit reduced secondhand 
aerosol exposure during mechanical ventilation 
by 94% in Servo–i and 88% in Hamilton Galileo 
ventilators.  Placement of  a collecting filter at the 
end of  the expiratory limb decreased secondhand 
aerosol exposure significantly both in Servo-i 
and Hamilton Galileo (p=0.0001 and p=0.004, 
respectively).
Discussion
The intent of  our study was to quantify the amount 
of  aerosol that is released into the environment 
from administration of  bronchodilators through a 
mechanical ventilator, and to determine the impact 
of  various forms of  expiratory filtration.  We found 
that the amount of  inhaled bronchodilator exiting 
the ventilator ranged from 0.25% to 45% of  a nominal 
dose placed in the nebuliser depending on the type 
of  filters used during mechanical ventilation.   
A standard small volume nebuliser operating 
continuously during administration of  
bronchodilators in an ambulatory setting typically 
has 0.8 – 1.2 mL of  medication remaining in the 
reservoir at the end of  nebulisation. With a 3 mL 
dose placed in the nebuliser, approximately 50 to 66% 
of  the nominal drug is emitted from the nebuliser as 
aerosol.  Consequently, the 45% of  dose we measured 
exiting the exhaust port of  the ventilator represents 
68 -90% of  all aerosol entering the ventilator circuit, 
identifying the ventilator as a rather efficient vehicle 
for aerosol transmission into the atmosphere.  Our 
findings suggest that any aerosol emitted into the 
ventilator circuit, whether from the nebuliser or the 
patient’s airway might be expected to pass through 
the ventilator circuit and exhaust port with similar 
efficiency.  At the time of  this study, there were 
no data identified in the literature investigating 
secondhand aerosol exposure during mechanical 
ventilation. Therefore, no comparison could be made 
to the data collected in this study.
However, it is very well known that respiratory 
therapists frequently administer aerosolised 
medications, with continuous small volume nebulisers 
which may spew 2/3s of  the emitted aerosol into 
the atmosphere.  When a portion of  the aerosolised 
medication enters the atmosphere, it exposes those 
individuals in the vicinity to inhalation of  these 
same medications along with the potential inhalation 
of  aerosolised organisms from the patients’ airways 
and lungs.27  Those who inhaled aerosol particles 
might be at risk of  exposure for unwanted side 
effects.  To verify that health care workers do, in 
fact, inhale portions of  the medication exhaust, 
Carnathan et al reported that respiratory therapists 
have traces of  inhaled medication in their plasma 
when exposed to aerosolised racemic S & R isomers 
of  albuterol.16 In a study by Shults et al, nurses and 
respiratory therapists were found to have ribavirin 
in their urine when they were exposed to patients 
receiving ribavirin treatments.28  Although none of  
these studies have been conducted on health-care 
professionals taking care of  ventilator-dependent 
patients, they all show that secondhand aerosol 
exposure and uptake may result in some side effects 
on individuals inhaling aerosolised medications.
According to the findings of  this study, using 
expiratory filters during mechanical ventilation 
decreases the risk of  exposure to aerosol released 
to atmosphere from the ventilator.  The proprietary 
filter tested was the most efficient option, with only 
0.25% of  dose escaping the exhaust port.  The other 
filter options allowed 8 – 24 fold more aerosols 
to pass through the exhaust into the ambient 
environment.  This difference could prove to be a 
critical difference with transmission of  infectious 
droplet nuclei entering into the ICU or any acute 
care facility. The case could be made that the higher 
level of  filtration efficiency should be considered the 
safer standard than use of  the less complex filters.  
Another aspect of  filter design is the amount of  
time that a filter can efficiently remove aerosols from 
gas prior to increasing resistance to flow of  that 
gas.  The greater the surface area of  the filtration 
elements the longer they can collect material prior 
to increase in resistance.  Simple filters have less 
internal area and may have increased resistance in a 
shorter period.  The difference in time to increased 
resistance may range from hours to days.  Changes 
in expiratory resistance in the ventilator circuit can 
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impact pressures and work of  breathing.  Filters 
should be selected which have the least impact in 
terms of  both time of  use before resistance changes, 
and the degree of  resistance changes that occur. 
Evaluation of  these parameters is beyond the limits 
of  this study. Therefore, future research on a broad 
scale is needed in order to understand clinical and 
environmental effects of  second-hand aerosol 
exposure during mechanical ventilation.
In conclusion, respiratory therapists, nurses, health 
care workers, patients and families are exposed 
to a variety of  infectious agents and aerosolised 
medications in the health care environment. As 
long as second-hand aerosol exposure continues to 
be a problem, health care professionals should be 
able to protect themselves from possible side effects 
of  second-hand aerosol exposure while caring 
for patient’s respiratory needs.  The results of  
our finding suggest that aerosol generated during 
mechanical ventilation can readily be transmitted to 
the ambient environment, and that simple measures 
such as use of  filters in the expiratory limb can 
greatly reduce risk of  second-hand aerosol exposure.
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